These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 12181051

  • 1. Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients.
    Pruneri G, Ponzoni M, Ferreri AJ, Decarli N, Tresoldi M, Raggi F, Baldessari C, Freschi M, Baldini L, Goldaniga M, Neri A, Carboni N, Bertolini F, Viale G.
    Br J Haematol; 2002 Sep; 118(3):817-20. PubMed ID: 12181051
    [Abstract] [Full Text] [Related]

  • 2. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
    Martone T, Rosso P, Albera R, Migliaretti G, Fraire F, Pignataro L, Pruneri G, Bellone G, Cortesina G.
    Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
    [Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
    Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S.
    Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
    Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, Yamada T, Hanaoka N, Inui K, Wada H.
    Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
    Yao Y, Kubota T, Takeuchi H, Sato K.
    Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
    [Abstract] [Full Text] [Related]

  • 6. Microvessel density assessment in benign and malignant endometrial changes.
    Czekierdowski A, Czekierdowska S, Czuba B, Cnota W, Sodowski K, Kotarski J, Zwirska-Korczala K.
    J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
    [Abstract] [Full Text] [Related]

  • 7. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
    Li C, Gardy R, Seon BK, Duff SE, Abdalla S, Renehan A, O'Dwyer ST, Haboubi N, Kumar S.
    Br J Cancer; 2003 May 06; 88(9):1424-31. PubMed ID: 12778073
    [Abstract] [Full Text] [Related]

  • 8. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
    Yang LY, Lu WQ, Huang GW, Wang W.
    BMC Cancer; 2006 May 02; 6():110. PubMed ID: 16650286
    [Abstract] [Full Text] [Related]

  • 9. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
    Barresi V, Cerasoli S, Vitarelli E, Tuccari G.
    Acta Neuropathol; 2007 Aug 02; 114(2):147-56. PubMed ID: 17594108
    [Abstract] [Full Text] [Related]

  • 10. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development.
    Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, Kinoshita J, Miyazaki M, Abe T.
    Surgery; 2002 Jan 02; 131(1 Suppl):S109-13. PubMed ID: 11821796
    [Abstract] [Full Text] [Related]

  • 11. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
    Salvesen HB, Gulluoglu MG, Stefansson I, Akslen LA.
    APMIS; 2003 Nov 02; 111(11):1011-8. PubMed ID: 14629267
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining.
    Ponzoni M, Savage DG, Ferreri AJ, Pruneri G, Viale G, Servida P, Bertolini F, Orazi A.
    Mod Pathol; 2004 Dec 02; 17(12):1513-20. PubMed ID: 15272276
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS, Kumar L, Dinda AK, Dawar R.
    Am J Hematol; 2006 Sep 02; 81(9):649-56. PubMed ID: 16845660
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.